DMVeille DM

Field safety notices: Cardionovum

Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.

1 authority publication by one authority, from 7 Jul 2020 to 7 Jul 2020.

Latest notice: 7 Jul 2020, IGJ, CARDIONOVUM GmbH, FSN-FO-40 no.11/2019, LEGFLOW OTW/RX Paclitaxel Releasing Peripheral Balloon Dilatation Catheter

Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Cardionovum or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.

1 distinct corrective action.

  1. CARDIONOVUM GmbH, FSN-FO-40 no.11/2019, LEGFLOW OTW/RX Paclitaxel Releasing Peripheral Balloon Dilatation Catheter

    Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026

The authorities that published these notices